Related Experiment Videos

Hyaline membrane disease treated with early nasal end-expiratory pressure: one year's experience

Pediatrics
|August 1, 1975
PubMed

Insights

Nasal end-expiratory pressure (NEEP) improved survival rates for infants with hyaline membrane disease (HMD), particularly those weighing 1,501 to 2,000 gm. This simple technique also significantly reduced the need for endotracheal intubation in HMD patients.

Area of Science:

  • Neonatal Medicine
  • Pediatric Respiratory Care

Background:

  • Hyaline membrane disease (HMD) is a significant cause of respiratory distress in newborns.
  • Traditional treatment often involved endotracheal intubation.

Purpose of the Study:

  • To evaluate the efficacy of nasal end-expiratory pressure (NEEP) in treating HMD.
  • To compare outcomes with and without early NEEP application.

Main Methods:

  • A retrospective analysis of 119 HMD infants treated between July 1973 and June 1974.
  • Comparison of survival rates, complications, and intubation rates with a previous cohort (1971-1972).
  • Early application of NEEP via nasopharyngeal tube in 69 infants.

Main Results:

  • Increased survival for all HMD admissions, statistically significant in infants weighing 1,501 to 2,000 gm (P < .01).
  • Significant decrease in endotracheal intubations required for HMD (P < .025).
  • No significant change in pneumothorax or bronchopulmonary dysplasia incidence.

Conclusions:

  • NEEP is a simple, effective method for providing continuous airway distending pressure in neonates.
  • Routine endotracheal intubation for infants needing only continuous airway distending pressure is no longer justified.
  • Early NEEP application enhances HMD treatment outcomes and reduces invasive procedures.

Related Concept Videos